Cargando…
Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer
The purpose of this study was to estimate the impact of metronomic therapy with oral tegafur-uracil (UFUR) following an intravenous FOLFOX regimen as surgical adjuvant chemotherapy on the overall survival (OS) and disease-free survival (DFS) of stage III colon cancer patients. From the retrospective...
Autores principales: | Huang, Wen-Yen, Ho, Ching-Liang, Lee, Chia-Cheng, Hsiao, Cheng-Wen, Wu, Chang-Chieh, Jao, Shu-Wen, Yang, Jen-Fu, Lo, Cheng-Hsiang, Chen, Jia-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362219/ https://www.ncbi.nlm.nih.gov/pubmed/28328969 http://dx.doi.org/10.1371/journal.pone.0174280 |
Ejemplares similares
-
Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and
dexamethasone for docetaxel-refractory prostate cancer
por: Kubota, Hiroki, et al.
Publicado: (2017) -
The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience
por: Yeh, Tsung-Jang, et al.
Publicado: (2021) -
Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022) -
Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
por: Yeh, Yung-Sung, et al.
Publicado: (2017) -
Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer: A nationwide cohort study and meta-analysis
por: Chen, Po-Huang, et al.
Publicado: (2021)